|
RALGAPB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.201000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.055800E-03 |
| Normal-vs-Stage2 |
3.209200E-01 |
| Normal-vs-Stage3 |
3.335000E-01 |
| Normal-vs-Stage4 |
1.116480E-03 |
| Stage1-vs-Stage2 |
7.486400E-01 |
| Stage1-vs-Stage3 |
6.519400E-01 |
| Stage1-vs-Stage4 |
2.919200E-01 |
| Stage2-vs-Stage3 |
9.513800E-01 |
| Stage2-vs-Stage4 |
2.517600E-01 |
| Stage3-vs-Stage4 |
2.574400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.909590E-02 |
| Normal-vs-AfricanAmerican |
1.974480E-02 |
| Normal-vs-Asian |
1.852380E-02 |
| Caucasian-vs-AfricanAmerican |
6.407400E-01 |
| Caucasian-vs-Asian |
2.105600E-01 |
| AfricanAmerican-vs-Asian |
4.425200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.955700E-04 |
| Normal-vs-Female |
8.342400E-01 |
| Male-vs-Female |
7.038500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.423630E-02 |
| Normal-vs-Extreme_Weight |
3.600000E-04 |
| Normal-vs-Obese |
3.515000E-01 |
| Normal-vs-Extreme_Obese |
4.611900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.410200E-01 |
| Normal_Weight-vs-Obese |
1.550960E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.781600E-01 |
| Extreme_Weight-vs-Obese |
3.148300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.823400E-01 |
| Obese-vs-Extreme_Obese |
2.092800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.397400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.331200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.836900E-04 |
| Normal-vs-Age(81-100Yrs) |
9.37130000044917E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.897800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.470000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.483200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.696100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.606400E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.396490E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.782300E-03 |
| Normal-VS-Type2 PRCC |
8.47019999999921E-05 |
| Normal-VS-KIRP CIMP |
8.475000E-01 |
| Normal-VS-Unclassified PRCC |
3.183200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.619700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.086800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.441900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.092400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.297600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.018000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.764300E-04 |
| Normal-vs-N1 |
4.192000E-01 |
| Normal-vs-N2 |
6.902000E-02 |
| N0-vs-N1 |
9.856400E-02 |
| N0-vs-N2 |
9.232400E-01 |
| N1-vs-N2 |
5.037400E-01 |
|
|
